Canada clears Uroplasty's next-generation bladder device:
This article was originally published in Clinica
Executive Summary
Canadian regulators have given Uroplasty the all-clear to sell a next-generation version of its Urgent PC neuromodulation system for treating overactive bladder symptoms of urge incontinence, urinary urgency and urinary frequency. The redesigned product comprises enhanced controls, visual and auditory signals of operational status and an ergonomic device shape, the Minnetonka, Minnesota firm said, adding that Canada was the first country to approve the new system. The ergonomic design and enhanced user interface offers clinicians ease of use, while effectively delivering percutaneous tibial nerve stimulation therapy, the company noted.